Cargando…

Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World Report

SIMPLE SUMMARY: Performing this real-world analysis, we intended to see if postoperative (adjuvant) systemic treatment outcomes in a Polish melanoma patient population are comparable to the results from international trials based on which the treatment was registered worldwide. We intended to provid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Placzke, Joanna, Rosińska, Magdalena, Sobczuk, Paweł, Ziętek, Marcin, Kempa-Kamińska, Natasza, Cybulska-Stopa, Bożena, Kamińska-Winciorek, Grażyna, Bal, Wiesław, Mackiewicz, Jacek, Galus, Łukasz, Las-Jankowska, Manuela, Jankowski, Michał, Dziura, Robert, Drucis, Kamil, Borkowska, Aneta, Świtaj, Tomasz, Rogala, Paweł, Kozak, Katarzyna, Klimczak, Anna, Jagodzińska-Mucha, Paulina, Szumera-Ciećkiewicz, Anna, Koseła-Paterczyk, Hanna, Rutkowski, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486524/ https://www.ncbi.nlm.nih.gov/pubmed/37686659 http://dx.doi.org/10.3390/cancers15174384

Ejemplares similares

Treatment of Locally Advanced Merkel Cell Carcinoma—A Multi-Center Study
por: Dudzisz-Sledz, Monika, et al.
Publicado: (2022)

Long-Term Outcomes of Targeted Therapy after First-Line Immunotherapy in BRAF-Mutated Advanced Cutaneous Melanoma Patients—Real-World Evidence
por: Rogala, Paweł, et al.
Publicado: (2022)

Long Term Results and Prognostic Biomarkers for Anti-PD1 Immunotherapy Used after BRAFi/MEKi Combination in Advanced Cutaneous Melanoma Patients
por: Rogala, Paweł, et al.
Publicado: (2022)

Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
por: Piejko, Karolina, et al.
Publicado: (2023)

The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy—Multicenter Italian–Polish Report
por: Placzke, Joanna, et al.
Publicado: (2022)

Efficacy of Neoadjuvant Targeted Therapy for Borderline Resectable III B-D or IV Stage BRAF (V600) Mutation-Positive Melanoma
por: Czarnecka, Anna M., et al.
Publicado: (2021)

The Use of ctDNA for BRAF Mutation Testing in Routine Clinical Practice in Patients with Advanced Melanoma
por: Sobczuk, Paweł, et al.
Publicado: (2022)

Analysis of efficacy and safety of vismodegib therapy in patients with advanced basal cell carcinoma – real world multicenter cohort study
por: Słowińska, M., et al.
Publicado: (2022)

Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study
por: Cybulska-Stopa, Bożena, et al.
Publicado: (2019)

Systemic Treatment for Advanced and Metastatic Malignant Peripheral Nerve Sheath Tumors—A Sarcoma Reference Center Experience
por: Sobczuk, Paweł, et al.
Publicado: (2020)

Efficacy and Safety of Hypofractionated Preoperative Radiotherapy for Primary Locally Advanced Soft Tissue Sarcomas of Limbs or Trunk Wall
por: Koseła-Paterczyk, Hanna, et al.
Publicado: (2021)

The Current Treatment Trends and Survival Patterns in Melanoma Patients with Positive Sentinel Lymph Node Biopsy (SLNB): A Multicenter Nationwide Study
por: Ziętek, Marcin, et al.
Publicado: (2023)

Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall: Results of a Single-Arm Prospective Clinical Trial
por: Koseła-Paterczyk, Hanna, et al.
Publicado: (2020)

Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2019)

Efficacy of Sirolimus Treatment in PEComa–10 Years of Practice Perspective
por: Świtaj, Tomasz, et al.
Publicado: (2021)

Neglected malignant neoplasms with cutaneous involvement
por: Kaminska-Winciorek, Grażyna, et al.
Publicado: (2021)

Immune-Related Thyroid Adverse Events Predict Response to PD-1 Blockade in Patients with Melanoma
por: Dawidowska, Anna, et al.
Publicado: (2022)

Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy
por: Teterycz, Pawel, et al.
Publicado: (2020)

Survival of patients with stage IIIC and IIID melanomas with nodal metastases in the light of new therapies
por: Ziętek, Marcin, et al.
Publicado: (2022)

Age as a Prognostic Factor in Patients with Ewing Sarcoma—The Polish Sarcoma Group Experience
por: Jagodzińska-Mucha, Paulina, et al.
Publicado: (2021)

Mutational landscape of primary and recurrent Ewing sarcoma
por: Jagodzińska-Mucha, Paulina, et al.
Publicado: (2021)

“Mistletoe sign”: probably a new dermoscopic descriptor for melanoma in situ and melanocytic junctional nevus in the inflammatory stage
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2013)

Epithelioid Sarcoma—From Genetics to Clinical Practice
por: Czarnecka, Anna M., et al.
Publicado: (2020)

The analysis of the long-term outcomes of sorafenib therapy in routine practice in imatinib and sunitinib resistant gastrointestinal stromal tumors (GIST)*
por: Rutkowski, Piotr, et al.
Publicado: (2017)

Mutation profile of primary subungual melanomas in Caucasians
por: Borkowska, Aneta, et al.
Publicado: (2020)

67P Detrimental effect of the COVID-19 pandemic on patients with adult extremity bone sarcoma: Reference center experience
por: Teterycz, P., et al.
Publicado: (2023)

The outcomes of Polish patients with advanced BRAF-positive melanoma treated with vemurafenib in a safety clinical trial
por: Rutkowski, Piotr, et al.
Publicado: (2015)

Predictive Biomarkers of Pathological Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Soft Tissue Sarcomas
por: Szumera-Ciećkiewicz, Anna, et al.
Publicado: (2023)

Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage
por: Teterycz, Pawel, et al.
Publicado: (2019)

Clinicopathological Features and Prognostic Factors of Primary Acral Melanomas in Caucasians
por: Borkowska, Aneta M., et al.
Publicado: (2020)

Characteristics of Giant Nodular Melanomas in Special Locations: a Case Series and Review of the Literature
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2022)

Feasibility and Long-Term Efficacy of PEComa Treatment—20 Years of Experience
por: Sobiborowicz, Aleksandra, et al.
Publicado: (2021)

The Long-Term Outcomes of Intensive Combined Therapy of Adult Patients with Localised Synovial Sarcoma
por: Kozak, Katarzyna, et al.
Publicado: (2020)

The Role of Pathology-Based Methods in Qualitative and Quantitative Approaches to Cancer Immunotherapy
por: Kuczkiewicz-Siemion, Olga, et al.
Publicado: (2022)

Dermoscopy of halo nevus in own observation
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2014)

Dermoscopy on nevus comedonicus: a case report and review of the literature
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2013)

Tips and tricks in the dermoscopy of pigmented lesions
por: Kaminska-Winciorek, Grazyna, et al.
Publicado: (2012)

The most common mistakes on dermatoscopy of melanocytic lesions
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2015)

Denosumab in Giant Cell Tumor of Bone: Multidisciplinary Medical Management Based on Pathophysiological Mechanisms and Real-World Evidence
por: Borkowska, Aneta Maria, et al.
Publicado: (2022)

Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications
por: Przybyl, Joanna, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_670mk3dlbsctdu8o2qjges43gj